2020-06-16T08:24:50-07:00 2019-06-30 743216978 NAWROCKI SMITH LLP 290 BROADHOLLOW RD STE 115E MELVILLE NY 117474822 990 2018-07-01 943342838 ANIMAL CANCER FOUNDATION ANIM 5165953012 191 MAIN STREET PORT WASHINGTON NY 11050 barbara cohen Executive Director 2020-06-16 true DAVID TELLIER P01359581 6317569500 2018 2020-09-23 17:36:50Z X Barbara Cohen 851208 false false X WWW.ACFOUNDATION.ORG X 1999 CA ACF develops and supports research that advances the prevention and treatment of cancer for people and pets. ACF focuses on furthering research in comparative oncology, which is the study of cancers that occur similarly in both companion animals and humans.To fund and develop research focused on the biologic similarity of cancer in pets and people that will expedite therapeutic and preventative benefits for both. Also, to inform the public and the scientific community about the biologic similarity of cancer in pets and people, and to communicate the ways in which comparative oncology will accelerate the treatment, prevention and ultimate eradication of cancer.The Canine Cancer Genome Project (CCGP) sponsored by Blue Buffalo Foundation and Animal Cancer Foundation seeks to map the seven most common canine cancer tumors and to place the datasets in the public domain for use by all cancer researchers. 7 7 2 15 0 282555 837412 0 12844 13083 4426 713 299825 851208 52500 49282 0 79661 133486 0 158890 122589 190311 254750 373079 45075 478129 897044 1418343 10793 55928 886251 1362415 ACF DEVELOPS AND SUPPORTS RESEARCH THAT ADVANCES THE PREVENTION AND TREATMENT OF CANCER FOR PEOPLE AND PETS. ACF FOCUSES ON FURTHERING RESEARCH IN COMPARATIVE ONCOLOGY, WHICH IS THE STUDY OF CANCERS THAT OCCUR SIMILARLY IN BOTH PETS AND HUMANS. false false 153401 The Canine Cancer Genome Project (CCGP) as described above received biospecimens donated by the CCOGC for the project. The scientific advisory council ("SAC"), composed of leaders in veterinary and human oncology, met and formulated request for Letters of Intent which was disseminated to a list they developed of the most qualified laboratories to conduct genetic sequencing. The CCGP scientific advisory council identified a multi-institutional research team and recommended that entity to the board of directors. The board of directors represented by pro-bono legal counsel at Eversheds Sutherland entered contract negotiations with the principal investigators. Due to the COVID19 crisis, the negotiation is tentatively to resume June 1, 2020.ACF has received $400,000 from the Blue Buffalo Foundation at the inception of the program. ACF is fundraising toward match goals. On December 20, 2018, Blue Buffalo entered a termination agreement with the Foundation, whereas Blue Buffalo wished to be released from its obligation with a payment of $540,000, this agreement totaling $940,000 in contributions under this agreement, so that Blue Buffalo may dissolve on December 31, 2018. While certain title provisions of the original agreement remain in effect, the Project is exclusive to the Foundation under the termination agreement.ACF Comparative Oncology Grant Award(s) are annual research grants of $50,000 for comparative oncology research that provides near-term benefit to pets with cancer while offering possibilities of translation to human cancer research and treatment. RFPs are opened in October of each year with proposals due in January of the following year. A scientific advisory council rates the proposals against the criteria in the RFP, the SAC meets via telephone conference to discuss the ratings and merits of competitively scored proposals, the SAC recommends a final award recipient to the board of directors, who approve the award. A grant agreement is made between ACF and the awarded institution and Primary Investigator prior to award being made.ACF Comparative Oncology Awareness Campaigns (various) provide information to the general public about the incidences of pet cancer, the similarities of human and canine cancer, the work being done in comparative oncology, and the need to develop science research in this area. Campaigns may be print, website, social media, informative.For the years ended June 30, 2019 and 2018, the Foundations fundraising expenses increased in order to raise funds and match the contributions of the Blue Buffalo Foundation, as per the condition in the grant contract (see Note 10). The funds raised will be used for program expenses related to the Canine Cancer Genome Project in future periods. Phase I of the Canine Cancer Genome Project agreement is in progress for the year ending June 30, 2020. It is expected that program expenses increase significantly in future periods. 153401 true true false false false false false false false false true false false false false false true false false false false true false false false false false false false false false false false false false false false false false false false true false false false false false false false false true 10 0 false 2 true false false false false false false false false 0 false false false false false false false false false false false false X 7 7 false false false false false false false true true false false true true true true true false true false false CA NY PA X X X BARBARA COHEN 5165953012 1129 NORTHERN BOULEVARD STE 404 MANHASSET NY 11030 X David Levine Director 3.00 0.00 X 0 0 0 Natasha Lunin Director 3.00 0.00 X 0 0 0 Jonathan Peris Director 3.00 0.00 X 0 0 0 Matthew Vuolo Director 3.00 0.00 X 0 0 0 Gerald Post President 3.00 0.00 X X 0 0 0 Theresa Botti Treasurer 3.00 0.00 X X 0 0 0 Jennifer Teitler Secretary 3.00 0.00 X X 0 0 0 Barbara Cohen Executive Director 40.00 0.00 X 74000 0 0 74000 0 false false false 0 837412 36078 837412 0 13083 13083 0 0 0 0 0 0 0 Miscellaneous 713 713 713 851208 13083 713 X 0 0 49282 49282 0 74000 30700 11000 32300 0 50000 20000 7500 22500 0 0 9486 3879 1415 4192 0 0 14532 14532 0 0 0 71221 27515 13527 30179 59155 1755 446 56954 4776 2262 2150 364 15030 9778 133 5119 0 0 321 274 47 0 0 0 0 5445 3570 1875 6059 189 5667 203 LICENSE AND PERMITS 4061 689 3372 Sponsorships 3000 3000 BANK FEES 2950 874 2076 Postage and Shipping 2692 542 863 1287 1069 655 70 344 373079 153401 60788 158890 565200 1074581 39685 46352 0 60000 69185 0 0 0 0 1391 2045 6476 6476 344 0 224262 224886 0 0 6162 1061 233 897044 1418343 10793 55928 10793 55928 X 460705 363293 425546 999122 886251 1362415 897044 1418343 478129 -1965 X false true X true false X 279830 290101 689330 282555 837412 2379228 0 0 279830 290101 689330 282555 837412 2379228 0 2379228 3266 4189 4255 4353 9011 25074 0 0 2404302 0.98960 0.98990 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 6476 6476 885321 -1965 36078 34113 851208 851208 409157 36078 36078 373079 373079 Vienna, Austria Cancer research 49282 Cash 1 false false false false false false X Legal Services 1 31380 FMV Graphic Design 1 4000 Pet Sympathy Cd 1 698 false false false Form 990, Part VI, Line 11b: Form 990 Review Process THE 990 DRAFT IS PROVIDED TO EACH BOARD MEMBER FOR COMPLETE REVIEW PRIOR TO FILING. Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts THE FOUNDATION MONITORS THEIR CONFLICT OF INTEREST POLICY AT THEIR BOARD MEETINGS. THE POLICY IS ENFORCED ON AN ONGOING BASIS. Form 990, Part VI, Line 15a: Compensation Review & Approval Process - CEO, Top Management THE FOUNDATION HAS TWO EMPLOYEES WHICH ARE THE EXECUTIVE DIRECTOR AND THE DIRECTOR OF DEVELOPMENT. THE BOARD MEETS ANNUALLY TO DISCUSS THE SALARY OF THE EXECUTIVE DIRECTOR. Form 990, Part VI, Line 19: Other Organization Documents Publicly Available ALL PUBLIC DOCUMENTS ARE MADE AVAILABLE UPON REQUEST AT THE FOUNDATION'S ADDRESS OF OPERATIONS, AS WELL AS ON THEIR WEBSITE